PubMed:9886419
Annnotations
jnlpba-st-training
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 14-18 | protein | denotes | IL-6 |
| T2 | 32-72 | cell_type | denotes | human peripheral blood mononuclear cells |
| T3 | 76-79 | protein | denotes | C3a |
| T4 | 84-95 | protein | denotes | C3a(desArg) |
| T5 | 101-114 | protein | denotes | anaphylatoxin |
| T6 | 115-118 | protein | denotes | C3a |
| T7 | 252-255 | protein | denotes | C3a |
| T8 | 260-271 | protein | denotes | C3a(desArg) |
| T9 | 316-320 | protein | denotes | IL-6 |
| T10 | 330-335 | cell_type | denotes | PBMCs |
| T11 | 380-388 | protein | denotes | IL-1beta |
| T12 | 390-393 | protein | denotes | C3a |
| T13 | 397-408 | protein | denotes | C3a(desArg) |
| T14 | 469-473 | protein | denotes | IL-6 |
| T15 | 489-493 | cell_type | denotes | PBMC |
| T16 | 522-530 | protein | denotes | IL-1beta |
| T17 | 537-540 | protein | denotes | C3a |
| T18 | 545-556 | protein | denotes | C3a(desArg) |
| T19 | 579-583 | protein | denotes | IL-6 |
| T20 | 595-599 | cell_type | denotes | PBMC |
| T21 | 634-637 | protein | denotes | C3a |
| T22 | 682-691 | cell_type | denotes | monocytes |
| T23 | 797-800 | protein | denotes | C3a |
| T24 | 951-954 | protein | denotes | C3a |
| T25 | 987-990 | protein | denotes | C3a |
| T26 | 994-998 | protein | denotes | IL-6 |
| T27 | 1047-1056 | cell_type | denotes | monocytes |
| T28 | 1093-1096 | protein | denotes | C3a |
| T29 | 1108-1119 | protein | denotes | C3a(desArg) |
| T30 | 1132-1145 | RNA | denotes | -induced mRNA |
| T31 | 1157-1161 | protein | denotes | IL-6 |
| T32 | 1179-1184 | cell_type | denotes | PBMCs |
| T33 | 1190-1205 | protein | denotes | pertussis toxin |
| T34 | 1231-1234 | protein | denotes | C3a |
| T35 | 1239-1250 | protein | denotes | C3a(desArg) |
| T36 | 1321-1330 | protein | denotes | G protein |
| T37 | 1392-1395 | protein | denotes | C3a |
| T38 | 1400-1411 | protein | denotes | C3a(desArg) |
| T39 | 1428-1437 | protein | denotes | NF-kappaB |
| T40 | 1442-1462 | protein | denotes | activating protein-1 |
| T41 | 1508-1517 | protein | denotes | NF-kappaB |
| T42 | 1522-1542 | protein | denotes | activating protein-1 |
| T43 | 1610-1613 | protein | denotes | C3a |
| T44 | 1634-1646 | protein | denotes | des-Arg form |
pubmed-sentences-benchmark
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| S1 | 0-96 | Sentence | denotes | Regulation of IL-6 synthesis in human peripheral blood mononuclear cells by C3a and C3a(desArg). |
| S2 | 97-206 | Sentence | denotes | The anaphylatoxin C3a has been reported to have immunomodulatory effects on a number of different cell types. |
| S3 | 207-389 | Sentence | denotes | In this study we investigated the effects of C3a and C3a(desArg) on gene expression and protein secretion of IL-6 in human PBMCs, either alone or in combination with LPS or IL-1beta. |
| S4 | 390-474 | Sentence | denotes | C3a or C3a(desArg) alone exhibited no effect on the expression or secretion of IL-6. |
| S5 | 475-627 | Sentence | denotes | However, when PBMC were stimulated with LPS or IL-1beta, both C3a and C3a(desArg) were found to enhance IL-6 release by PBMC in a dose-dependent manner. |
| S6 | 628-867 | Sentence | denotes | Since C3a has been shown to induce PGE2 production by monocytes, and PGE2 has been shown to influence cytokine production, we investigated the potential role of PGE2 in C3a-mediated enhancement of LPS- and IL-1beta-induced IL-6 production. |
| S7 | 868-1057 | Sentence | denotes | Indomethacin blocked PGE2 release, but had no influence on the observed effects of C3a, suggesting that the effects of C3a on IL-6 production are independent of PGE2 formation by monocytes. |
| S8 | 1058-1162 | Sentence | denotes | Northern blot analysis showed that C3a as well as C3a(desArg) enhanced LPS-induced mRNA levels for IL-6. |
| S9 | 1163-1347 | Sentence | denotes | Pretreatment of PBMCs with pertussis toxin blocked the functions of C3a and C3a(desArg), indicating that the actions of these two molecules are mediated by a G protein-coupled pathway. |
| S10 | 1348-1471 | Sentence | denotes | Furthermore, we investigated the effects of C3a and C3a(desArg) on induction of NF-kappaB and activating protein-1 binding. |
| S11 | 1472-1560 | Sentence | denotes | Both molecules enhanced LPS-induced NF-kappaB and activating protein-1 binding activity. |
| S12 | 1561-1689 | Sentence | denotes | These results demonstrate the capacity of intact C3a and its circulating des-Arg form to exert immunmodulatory effects in vitro. |
genia-medco-coref
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| C2 | 76-79 | NP | denotes | C3a |
| C3 | 84-95 | NP | denotes | C3a(desArg) |
| C1 | 76-95 | NP | denotes | C3a and C3a(desArg) |
| C4 | 97-118 | NP | denotes | The anaphylatoxin C3a |
| C5 | 145-169 | NP | denotes | immunomodulatory effects |
| C7 | 252-255 | NP | denotes | C3a |
| C8 | 260-271 | NP | denotes | C3a(desArg) |
| C6 | 252-271 | NP | denotes | C3a and C3a(desArg) |
| C9 | 316-320 | NP | denotes | IL-6 |
| C10 | 324-335 | NP | denotes | human PBMCs |
| C11 | 373-388 | NP | denotes | LPS or IL-1beta |
| C12 | 390-393 | NP | denotes | C3a |
| C13 | 397-408 | NP | denotes | C3a(desArg) |
| C14 | 469-473 | NP | denotes | IL-6 |
| C15 | 489-493 | NP | denotes | PBMC |
| C16 | 515-530 | NP | denotes | LPS or IL-1beta |
| C18 | 537-540 | NP | denotes | C3a |
| C19 | 545-556 | NP | denotes | C3a(desArg) |
| C17 | 532-556 | NP | denotes | both C3a and C3a(desArg) |
| C20 | 595-599 | NP | denotes | PBMC |
| C21 | 634-637 | NP | denotes | C3a |
| C22 | 682-691 | NP | denotes | monocytes |
| C23 | 697-701 | NP | denotes | PGE2 |
| C24 | 789-793 | NP | denotes | PGE2 |
| C25 | 825-866 | NP | denotes | LPS- and IL-1beta-induced IL-6 production |
| C26 | 951-954 | NP | denotes | C3a |
| C27 | 987-990 | NP | denotes | C3a |
| C28 | 994-1009 | NP | denotes | IL-6 production |
| C29 | 1047-1056 | NP | denotes | monocytes |
| C30 | 1093-1096 | NP | denotes | C3a |
| C31 | 1108-1119 | NP | denotes | C3a(desArg) |
| C32 | 1157-1161 | NP | denotes | IL-6 |
| C33 | 1179-1184 | NP | denotes | PBMCs |
| C35 | 1231-1234 | NP | denotes | C3a |
| C36 | 1239-1250 | NP | denotes | C3a(desArg) |
| C34 | 1231-1250 | NP | denotes | C3a and C3a(desArg) |
| C37 | 1283-1302 | NP | denotes | these two molecules |
| C39 | 1392-1395 | NP | denotes | C3a |
| C40 | 1400-1411 | NP | denotes | C3a(desArg) |
| C38 | 1392-1411 | NP | denotes | C3a and C3a(desArg) |
| C41 | 1472-1486 | NP | denotes | Both molecules |
| C42 | 1603-1613 | NP | denotes | intact C3a |
| C44 | 1618-1621 | NP | denotes | its |
| C43 | 1618-1646 | NP | denotes | its circulating des-Arg form |
| C45 | 1656-1679 | NP | denotes | immunmodulatory effects |
| R1 | C4 | C2 | coref-ident | The anaphylatoxin C3a,C3a |
| R2 | C7 | C4 | coref-ident | C3a,The anaphylatoxin C3a |
| R3 | C8 | C3 | coref-ident | C3a(desArg),C3a(desArg) |
| R4 | C6 | C1 | coref-ident | C3a and C3a(desArg),C3a and C3a(desArg) |
| R5 | C12 | C7 | coref-ident | C3a,C3a |
| R6 | C13 | C8 | coref-ident | C3a(desArg),C3a(desArg) |
| R7 | C14 | C9 | coref-ident | IL-6,IL-6 |
| R8 | C15 | C10 | coref-ident | PBMC,human PBMCs |
| R9 | C16 | C11 | coref-ident | LPS or IL-1beta,LPS or IL-1beta |
| R10 | C18 | C12 | coref-ident | C3a,C3a |
| R11 | C19 | C13 | coref-ident | C3a(desArg),C3a(desArg) |
| R12 | C17 | C6 | coref-ident | both C3a and C3a(desArg),C3a and C3a(desArg) |
| R13 | C20 | C15 | coref-ident | PBMC,PBMC |
| R14 | C21 | C18 | coref-ident | C3a,C3a |
| R15 | C24 | C23 | coref-ident | PGE2,PGE2 |
| R16 | C26 | C21 | coref-ident | C3a,C3a |
| R17 | C27 | C26 | coref-ident | C3a,C3a |
| R18 | C28 | C25 | coref-ident | IL-6 production,LPS- and IL-1beta-induced IL-6 production |
| R19 | C29 | C22 | coref-ident | monocytes,monocytes |
| R20 | C30 | C27 | coref-ident | C3a,C3a |
| R21 | C31 | C19 | coref-ident | C3a(desArg),C3a(desArg) |
| R22 | C32 | C14 | coref-ident | IL-6,IL-6 |
| R23 | C33 | C20 | coref-ident | PBMCs,PBMC |
| R24 | C35 | C30 | coref-ident | C3a,C3a |
| R25 | C36 | C31 | coref-ident | C3a(desArg),C3a(desArg) |
| R26 | C34 | C17 | coref-ident | C3a and C3a(desArg),both C3a and C3a(desArg) |
| R27 | C37 | C34 | coref-ident | these two molecules,C3a and C3a(desArg) |
| R28 | C39 | C35 | coref-ident | C3a,C3a |
| R29 | C40 | C36 | coref-ident | C3a(desArg),C3a(desArg) |
| R30 | C38 | C37 | coref-ident | C3a and C3a(desArg),these two molecules |
| R31 | C41 | C38 | coref-pron | Both molecules,C3a and C3a(desArg) |
| R32 | C44 | C42 | coref-pron | its,intact C3a |
| R33 | C43 | C40 | coref-ident | its circulating des-Arg form,C3a(desArg) |
| R34 | C45 | C5 | coref-ident | immunmodulatory effects,immunomodulatory effects |
GENIAcorpus
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 14-18 | protein_molecule | denotes | IL-6 |
| T2 | 32-72 | cell_type | denotes | human peripheral blood mononuclear cells |
| T3 | 76-79 | protein_molecule | denotes | C3a |
| T4 | 84-95 | protein_molecule | denotes | C3a(desArg) |
| T5 | 101-114 | protein_family_or_group | denotes | anaphylatoxin |
| T6 | 115-118 | protein_molecule | denotes | C3a |
| T7 | 252-255 | protein_molecule | denotes | C3a |
| T8 | 260-271 | protein_molecule | denotes | C3a(desArg) |
| T9 | 275-290 | other_name | denotes | gene expression |
| T10 | 295-312 | other_name | denotes | protein secretion |
| T11 | 316-320 | protein_molecule | denotes | IL-6 |
| T12 | 330-335 | cell_type | denotes | PBMCs |
| T13 | 373-376 | lipid | denotes | LPS |
| T14 | 380-388 | protein_molecule | denotes | IL-1beta |
| T15 | 390-393 | protein_molecule | denotes | C3a |
| T16 | 397-408 | protein_molecule | denotes | C3a(desArg) |
| T17 | 469-473 | protein_molecule | denotes | IL-6 |
| T18 | 489-493 | cell_type | denotes | PBMC |
| T19 | 515-518 | lipid | denotes | LPS |
| T20 | 522-530 | protein_molecule | denotes | IL-1beta |
| T21 | 537-540 | protein_molecule | denotes | C3a |
| T22 | 545-556 | protein_molecule | denotes | C3a(desArg) |
| T23 | 579-583 | protein_molecule | denotes | IL-6 |
| T24 | 595-599 | cell_type | denotes | PBMC |
| T25 | 605-626 | other_name | denotes | dose-dependent manner |
| T26 | 634-637 | protein_molecule | denotes | C3a |
| T27 | 663-667 | lipid | denotes | PGE2 |
| T28 | 682-691 | cell_type | denotes | monocytes |
| T29 | 697-701 | lipid | denotes | PGE2 |
| T30 | 789-793 | lipid | denotes | PGE2 |
| T31 | 797-800 | protein_molecule | denotes | C3a |
| T32 | 889-893 | lipid | denotes | PGE2 |
| T33 | 951-954 | protein_molecule | denotes | C3a |
| T34 | 987-990 | protein_molecule | denotes | C3a |
| T35 | 994-998 | protein_molecule | denotes | IL-6 |
| T36 | 1029-1033 | lipid | denotes | PGE2 |
| T37 | 1047-1056 | cell_type | denotes | monocytes |
| T38 | 1058-1080 | other_name | denotes | Northern blot analysis |
| T39 | 1093-1096 | protein_molecule | denotes | C3a |
| T40 | 1108-1119 | protein_molecule | denotes | C3a(desArg) |
| T41 | 1129-1132 | lipid | denotes | LPS |
| T42 | 1132-1145 | RNA_family_or_group | denotes | -induced mRNA |
| T43 | 1157-1161 | protein_molecule | denotes | IL-6 |
| T44 | 1179-1184 | cell_type | denotes | PBMCs |
| T45 | 1190-1205 | protein_molecule | denotes | pertussis toxin |
| T46 | 1231-1234 | protein_molecule | denotes | C3a |
| T47 | 1239-1250 | protein_molecule | denotes | C3a(desArg) |
| T48 | 1321-1330 | protein_family_or_group | denotes | G protein |
| T49 | 1392-1395 | protein_molecule | denotes | C3a |
| T50 | 1400-1411 | protein_molecule | denotes | C3a(desArg) |
| T51 | 1428-1437 | protein_complex | denotes | NF-kappaB |
| T52 | 1442-1462 | protein_molecule | denotes | activating protein-1 |
| T53 | 1496-1499 | lipid | denotes | LPS |
| T54 | 1508-1517 | protein_complex | denotes | NF-kappaB |
| T55 | 1522-1542 | protein_molecule | denotes | activating protein-1 |
| T56 | 1610-1613 | protein_molecule | denotes | C3a |
| T57 | 1634-1646 | protein_molecule | denotes | des-Arg form |
| T58 | 1656-1679 | other_name | denotes | immunmodulatory effects |